申请人:Hoechst Marion Roussel, Inc.
公开号:US06017923A1
公开(公告)日:2000-01-25
##STR1## The present invention is directed to a class of novel carbocyclic derivatives having formulas (I) and (II) and their use as anti-viral and anti-neoplastic agents, wherein X.sub.1 and X.sub.2 are each independently hydrogen, fluorine, or chlorine, R is hydrogen or hydroxymethyl, J is a radical of formulas (a), (b) and (c). Y.sub.1 is a CH group, a CCl group, a CBr group or a CNH.sub.2 group, Y.sub.2 and Y.sub.3 are each independently nitrogen or a CH group, Y.sub.1 is a CH group, a CCl group, a CBr group or a CNH.sub.2 group, Y.sub.2 and Y.sub.3 are each independently nitrogen or a CH group, Y.sub.4 is hydrogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy or halogen, Y.sub.5 is NH.sub.2 or C.sub.1 -C.sub.4 alkoxy, Q is NH.sub.2, NHOH, NHCH.sub.3, OH, or hydrogen, and V is hydrogen, halogen or NH.sub.2 ; or a pharmaceutically acceptable salt thereof.
本发明涉及一类新型的碳环衍生物,其化学式为(I)和(II),并将其用作抗病毒和抗肿瘤药物,其中X1和X2各自独立地为氢、氟或氯,R为氢或羟甲基,J为式(a)、(b)和(c)的基团。Y1是一个CH基团、一个CCl基团、一个CBr基团或一个CNH2基团,Y2和Y3各自独立地为氮或一个CH基团,Y1是一个CH基团、一个CCl基团、一个CBr基团或一个CNH2基团,Y2和Y3各自独立地为氮或一个CH基团,Y4为氢、C1-C4烷基、C1-C4烷氧基或卤素,Y5为NH2或C1-C4烷氧基,Q为NH2、NHOH、NHCH3、OH或氢,V为氢、卤素或NH2;或其药学上可接受的盐。